This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2004;6(2):122-7.

doi: 10.1080/14653240410005267.

DC-based cancer vaccines: lessons from clinical trials

J D Brody¹, E G Engleman

Affiliations

PMID: 15203988
DOI: 10.1080/14653240410005267

Review

DC-based cancer vaccines: lessons from clinical trials

J D Brody et al. Cytotherapy. 2004.

. 2004;6(2):122-7.

doi: 10.1080/14653240410005267.

Authors

J D Brody¹, E G Engleman

Affiliation

¹ Department of Pathology, Stanford University School of Medicine, CA, Stanford, USA.

PMID: 15203988
DOI: 10.1080/14653240410005267

No abstract available

PubMed Disclaimer

Similar articles

DC therapy for metastatic melanoma.
Ingram SB, O'Rourke MG. Ingram SB, et al. Cytotherapy. 2004;6(2):148-53. doi: 10.1080/14653240410005627. Cytotherapy. 2004. PMID: 15203991 Review. No abstract available.
Generation of dendritic cell-based vaccines for cancer therapy.
Reinhard G, Märten A, Kiske SM, Feil F, Bieber T, Schmidt-Wolf IG. Reinhard G, et al. Br J Cancer. 2002 May 20;86(10):1529-33. doi: 10.1038/sj.bjc.6600316. Br J Cancer. 2002. PMID: 12085199 Free PMC article. Review.
How much help does a vaccine-induced T-cell response need?
Weber JS, Mulé JJ. Weber JS, et al. J Clin Invest. 2001 Mar;107(5):553-4. doi: 10.1172/JCI12403. J Clin Invest. 2001. PMID: 11238555 Free PMC article. No abstract available.
Genetically modified dendritic cells in cancer immunotherapy: a better tomorrow?
Shurin MR, Gregory M, Morris JC, Malyguine AM. Shurin MR, et al. Expert Opin Biol Ther. 2010 Nov;10(11):1539-53. doi: 10.1517/14712598.2010.526105. Expert Opin Biol Ther. 2010. PMID: 20955111 Review.
DCs in lymphoma--biology and therapeutic aspects.
Schultze JL, Fiore F, von Bergwelt-Baildon M. Schultze JL, et al. Cytotherapy. 2004;6(2):138-47. doi: 10.1080/14653240410006095. Cytotherapy. 2004. PMID: 15203990 Review. No abstract available.

See all similar articles

Cited by

Strategies for Small Extracellular Vesicle-Based Cancer Immunotherapy.
Chen Y, Tang S, Cai F, Wan Y. Chen Y, et al. Research (Wash D C). 2024 Jul 22;7:0421. doi: 10.34133/research.0421. eCollection 2024. Research (Wash D C). 2024. PMID: 39040921 Free PMC article. Review.
Comparing the ability of freshly generated and cryopreserved dendritic cell vaccines to inhibit growth of breast cancer in a mouse model.
Radhakrishnan AK, Sim GC, Cheong SK. Radhakrishnan AK, et al. Biores Open Access. 2012 Oct;1(5):239-46. doi: 10.1089/biores.2012.0229. Biores Open Access. 2012. PMID: 23515111 Free PMC article.
Dendritic cells engineered to express CD40L continuously produce IL12 and resist negative signals from Tr1/Th3 dominated tumors.
Loskog A, Ninalga C, Tötterman TH. Loskog A, et al. Cancer Immunol Immunother. 2006 May;55(5):588-97. doi: 10.1007/s00262-005-0051-4. Epub 2005 Sep 21. Cancer Immunol Immunother. 2006. PMID: 16175400 Free PMC article.
Made to Measure: Patient-Tailored Treatment of Multiple Sclerosis Using Cell-Based Therapies.
Wens I, Janssens I, Derdelinckx J, Meena M, Willekens B, Cools N. Wens I, et al. Int J Mol Sci. 2021 Jul 14;22(14):7536. doi: 10.3390/ijms22147536. Int J Mol Sci. 2021. PMID: 34299154 Free PMC article. Review.
Optimizing dendritic cell-based immunotherapy: tackling the complexity of different arms of the immune system.
Van Brussel I, Berneman ZN, Cools N. Van Brussel I, et al. Mediators Inflamm. 2012;2012:690643. doi: 10.1155/2012/690643. Epub 2012 Jul 18. Mediators Inflamm. 2012. PMID: 22851815 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

Grants and funding

HL57443/HL/NHLBI NIH HHS/United States

LinkOut - more resources

Full Text Sources
- Elsevier Science